share_log

Reviewing Pro-Dex (NASDAQ:PDEX) & ICU Medical (NASDAQ:ICUI)

Reviewing Pro-Dex (NASDAQ:PDEX) & ICU Medical (NASDAQ:ICUI)

審查專業-塞克斯(納斯達克:PDEX)和重症監護病房醫療(納斯達克:ICUI)
Defense World ·  2022/12/16 01:51

Pro-Dex (NASDAQ:PDEX – Get Rating) and ICU Medical (NASDAQ:ICUI – Get Rating) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, risk, valuation, dividends and analyst recommendations.

親德克斯(納斯達克:PDEX-GET評級)和ICU醫療(納斯達克:ICUI-GET評級)都是醫療公司,但哪隻股票更好?我們將根據這兩家公司的盈利能力、機構所有權、收益、風險、估值、股息和分析師建議來比較它們的實力。

Volatility & Risk

波動性與風險

Pro-Dex has a beta of 0.91, indicating that its stock price is 9% less volatile than the S&P 500. Comparatively, ICU Medical has a beta of 0.54, indicating that its stock price is 46% less volatile than the S&P 500.

Pro-Dex的貝塔係數為0.91,表明其股價的波動性比標準普爾500指數低9%。相比之下,ICU Medical的貝塔係數為0.54,表明其股價的波動性比標準普爾500指數低46%。

Get
到達
Pro-Dex
支持Dex
alerts:
警報:

Institutional & Insider Ownership

機構與內部人持股

13.7% of Pro-Dex shares are held by institutional investors. Comparatively, 90.2% of ICU Medical shares are held by institutional investors. 42.6% of Pro-Dex shares are held by company insiders. Comparatively, 7.3% of ICU Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

機構投資者持有Pro-Dex公司13.7%的股份。相比之下,ICU Medical 90.2%的股份由機構投資者持有。42.6%的Pro-Dex股票由公司內部人士持有。相比之下,ICU醫療7.3%的股份由公司內部人士持有。強大的機構持股表明,捐贈基金、大型基金管理公司和對衝基金相信,一隻股票有望實現長期增長。

Analyst Recommendations

分析師建議

This is a breakdown of current recommendations and price targets for Pro-Dex and ICU Medical, as reported by MarketBeat.
據MarketBeat報道,這是Pro-Dex和ICU Medical目前的建議和價格目標的細目。
Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Pro-Dex 0 0 0 0 N/A
ICU Medical 0 1 1 0 2.50
銷售評級 保持評級 購買評級 強勁的買入評級 評級分數
支持Dex 0 0 0 0 不適用
ICU醫療 0 1 1 0 2.50

Pro-Dex currently has a consensus price target of $30.00, indicating a potential upside of 72.52%. ICU Medical has a consensus price target of $195.00, indicating a potential upside of 23.29%. Given Pro-Dex's higher possible upside, equities research analysts plainly believe Pro-Dex is more favorable than ICU Medical.

Pro-Dex目前的共識目標價為30.00美元,表明潛在上行空間為72.52%。ICU Medical的共識目標價為195.00美元,表明潛在漲幅為23.29%。考慮到Pro-Dex的更高可能上行空間,股票研究分析師顯然認為Pro-Dex比ICU Medical更有利。

Earnings and Valuation

收益和估值

This table compares Pro-Dex and ICU Medical's revenue, earnings per share and valuation.

此表比較了Pro-Dex和ICU Medical的收入、每股收益和估值。

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Pro-Dex $42.04 million 1.48 $3.86 million $1.04 16.72
ICU Medical $1.32 billion 2.88 $103.14 million ($1.56) -101.39
總收入 價格/銷售額比 淨收入 每股收益 市盈率
支持Dex 4,204萬美元 1.48 386萬美元 $1.04 16.72
ICU醫療 13.2億美元 2.88 1.0314億美元 ($1.56) -101.39

ICU Medical has higher revenue and earnings than Pro-Dex. ICU Medical is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks.

ICU Medical的收入和收益比Pro-Dex更高。ICU Medical的市盈率低於Pro-Dex,表明它目前是兩隻股票中更負擔得起的一隻。

Profitability

盈利能力

This table compares Pro-Dex and ICU Medical's net margins, return on equity and return on assets.

此表比較了Pro-Dex和ICU Medical的淨利潤率、股本回報率和資產回報率。

Net Margins Return on Equity Return on Assets
Pro-Dex 8.97% 16.75% 8.53%
ICU Medical -1.90% 6.51% 3.28%
淨利潤率 股本回報率 資產回報率
支持Dex 8.97% 16.75% 8.53%
ICU醫療 -1.90% 6.51% 3.28%

Summary

摘要

Pro-Dex beats ICU Medical on 8 of the 13 factors compared between the two stocks.

在兩隻股票之間進行比較的13個因素中,有8個是Pro-Dex擊敗了ICU Medical。

About Pro-Dex

關於Pro-Dex

(Get Rating)

(獲取評級)

Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company was founded in 1978 and is headquartered in Irvine, California.

Pro-Dex公司為世界各地的醫療器械原始設備製造商設計、開發、製造和銷售動力手術器械。該公司提供可高壓滅菌、電池供電和電動的多功能外科驅動程序和剃鬚刀,主要用於整形外科、胸部和顱頜面部市場。它還提供工程、質量和監管諮詢服務;並向各種行業製造和銷售旋轉空氣馬達。該公司成立於1978年,總部設在加利福尼亞州歐文。

About ICU Medical

關於ICU醫療

(Get Rating)

(獲取評級)

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap and SwabTip disinfecting caps; Tego hemodialysis connectors; ClearGuard HD, an antimicrobial barrier cap for hemodialysis catheters; and ChemoClave and ChemoLock closed system transfer devices, as well as Diana hazardous drug compounding system for the preparation of hazardous drugs. It also provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. The company offers infusion pumps under the Plum 360 and LifeCare PCA brands; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform that connects smart pumps to hospital's electronic health records, asset tracking systems, and alarm notification platforms; and related professional services. It also provides critical care products, such as Cogent 2-in-1 and CardioFlo hemodynamic monitoring systems; TDQ and OptiQ cardiac output monitoring catheters; TriOx venous oximetry catheters; Transpac blood pressure transducers; and SafeSet closed blood sampling and conservation systems. The company sells its products to acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is headquartered in San Clemente, California.

ICU醫療公司及其子公司在全球範圍內開發、製造和銷售用於輸液治療和危重護理應用的醫療設備。該公司的輸液治療產品包括MicroClave、MicroClave Clear和NanoClave品牌的無針產品;中子導管通暢設備;SwabCap和SwabTip消毒帽;Tego血液透析連接器;ClearGuard HD,血液透析導管的抗菌屏障帽;ChemoClave和ChemoLock封閉式系統傳輸設備,以及用於製備危險藥物的Diana危險藥物複合系統。它還提供靜脈治療和稀釋劑,如氯化鈉、葡萄糖、平衡電解質溶液、乳酸林格氏症、林格氏症、甘露醇、氯化鈉/葡萄糖和無菌水;灌溉包括氯化鈉和無菌水灌溉、生理溶液、林格氏灌溉、醋酸灌溉、甘氨酸灌溉、山梨醇-甘露醇灌溉、彈性容器和灌裝瓶選項。該公司提供Plum 360和LifeCare PCA品牌的輸液泵;IV中介安全軟件,包括ICU Medical MedNet,這是一個企業級藥物管理平臺,將智能泵連接到醫院的電子健康記錄、資產跟蹤系統和警報通知平臺;以及相關專業服務。該公司還提供重症監護產品,如Cogent二合一和心臟Flo血流動力學監測系統;TDQ和OptiQ心輸出量監測導管;TriOx靜脈血氧儀導管;TRANSPAC血壓傳感器;以及SafeSet封閉式血液採樣和保存系統。該公司將其產品銷售給急性護理醫院、批發商、門診診所和備用場所設施,包括門診診所、家庭保健提供者和長期護理設施。ICU醫療, 公司成立於1984年,總部設在加利福尼亞州聖克萊門特。

Receive News & Ratings for Pro-Dex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro-Dex and related companies with MarketBeat.com's FREE daily email newsletter.

接受Pro-Dex Daily的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Pro-Dex和相關公司的最新新聞和分析師評級的每日簡要摘要。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論